Erica Rogers - Mar 2, 2021 Form 4 Insider Report for Silk Road Medical Inc (SILK)

Signature
/s/Mhairi Jones, by power of attorney
Stock symbol
SILK
Transactions as of
Mar 2, 2021
Transactions value $
-$93,478
Form type
4
Date filed
9/29/2023, 06:00 PM
Next filing
May 12, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SILK Common Stock Sale -$93.5K -1.65K -0.61% $56.62 268K Mar 2, 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on September 11, 2020, prior to the effectiveness of the revised requirements of Rule 10b5-1(c). In compliance with SEC guidance, the Reporting Person has not checked the box above but states that the Rule 10b5-1 trading plan is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
F2 This transaction was executed in multiple trades at price ranging from $56.55 to $56.70. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.